Company Profile | February 28, 2014

2014 CRO Leadership Awards Winner

eurofins logo

Categories Won:

  1. Quality

  2. Reliability

  3. Productivity

  4. Innovation

 

Drug Life Cycle Stages:

  • Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3)
  • Drug Substance Production: Primary Process Development, Drug Substance Production
  • Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics

Main Service Areas:
Clinical, Preclinical

Services & Capabilities:
Method development/optimization, validation/qualification/transfer, product release testing, stability storage & testing, raw materials testing, impurities & residuals testing, characterization, cell banking, cell line characterization, viral clearance, bioassays, professional scientific staffingSM

Therapeutic Areas:
As a testing laboratory, we support all therapeutic areas of large and small molecule products. Most  importantly, we have expertise in various modalities, including synthetic small molecule  pharmaceuticals, as well as cell and gene therapy, synthetic peptides, therapeutic proteins, conjugates, therapeutic enzymes, and vaccines.

Dr. Timothy Oostdyk

president

“It is an honor to receive the CRO Leadership Award for quality, reliability, innovation, and productivity again this year. At Eurofins Lancaster Laboratories, we work extremely hard every day to deliver the most comprehensive, reliable, and timely GMP testing available for large and small molecule products. We are delighted
that the bio/pharmaceutical industry continues to recognize Eurofins Lancaster Laboratories as a leader in these key areas.”